Astal Laboratories Limited (BOM:512600)
India flag India · Delayed Price · Currency is INR
69.54
-1.37 (-1.93%)
At close: Oct 1, 2026

Astal Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,2212,486637.41236.536.072.11
Revenue Growth
325.99%290.08%169.51%555.71%1611.01%3.80%
Operating Income
252.88177.07119.7810.870.32-0.12
Net Income
220.42147.0989.257.850.16-0.17
Earnings Per Share
5.267.818.041.550.04-0.04
EPS Growth
-34.38%-2.86%417.52%3689.19%--

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
13.017.0317.360.770.840.18
Total Debt
498.93498.92132.683.12--
Net Cash (Debt)
-485.92-491.9-115.3857.640.840.18
Net Cash Growth
---6729.74%361.20%-41.52%
Net Cash Per Share
-11.59-26.12-10.3911.410.210.05

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--176.99-125.17-55.79-14.37-2.49
Capital Expenditures
--13.93-57.75-59.17--
Free Cash Flow
--190.91-182.92-114.96-14.37-2.49
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Margin
7.85%7.12%18.79%4.59%0.89%-5.74%
Pretax Margin
7.85%7.13%18.79%4.59%0.89%-8.06%
Profit Margin
6.84%5.92%14.00%3.32%0.46%-8.11%
FCF Margin
--7.68%-28.70%-48.61%-39.83%-118.03%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
13.2318.768.3751.21720.07-
PS Ratio
0.951.111.171.703.2730.52